Timeline
More in Technology
Beximco Pharma delivers first doses of generic cystic fibrosis treatment at 96% discount to US price
Beximco Pharmaceuticals has supplied the first patients with its generic version of elexacaftor/tezacaftor/ivacaftor, priced at $12,750 per year against a US list price of approximately $370,000.